P. Schlag

8.0k total citations
185 papers, 5.8k citations indexed

About

P. Schlag is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Schlag has authored 185 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 47 papers in Surgery and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Schlag's work include Gastric Cancer Management and Outcomes (23 papers), Colorectal Cancer Treatments and Studies (20 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). P. Schlag is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), Colorectal Cancer Treatments and Studies (20 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). P. Schlag collaborates with scholars based in Germany, United States and United Kingdom. P. Schlag's co-authors include Christian Herfarth, Peter Hohenberger, C Herfarth, Volker Sandig, Christian Hofmann, Mike Strauss, Gary Jennings, Jörg Mengwasser, V. Schwarz and Elke Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

P. Schlag

178 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Schlag Germany 41 1.8k 1.8k 1.6k 1.1k 796 185 5.8k
Toshiharu Kamura Japan 41 1.5k 0.8× 2.1k 1.2× 1.4k 0.9× 787 0.7× 318 0.4× 188 7.5k
Simon Karpatkin United States 55 1.5k 0.8× 1.7k 1.0× 958 0.6× 1.6k 1.4× 325 0.4× 206 9.8k
El–Nasir Lalani United Kingdom 38 1.1k 0.6× 2.7k 1.5× 848 0.5× 699 0.6× 684 0.9× 119 5.1k
Mehrdad Nadji United States 41 1.7k 1.0× 1.6k 0.9× 1.0k 0.6× 956 0.8× 346 0.4× 169 5.6k
Chandan Guha United States 48 2.0k 1.1× 2.2k 1.2× 1.5k 0.9× 1.4k 1.2× 1.2k 1.5× 267 7.1k
Phil Gold Canada 34 2.4k 1.3× 2.4k 1.3× 905 0.6× 1.0k 0.9× 2.1k 2.7× 94 6.6k
Andrea Abati United States 38 1.9k 1.0× 1.1k 0.6× 807 0.5× 945 0.8× 242 0.3× 97 4.6k
Stefania Staibano Italy 43 2.4k 1.3× 2.8k 1.6× 915 0.6× 1.2k 1.1× 308 0.4× 229 6.5k
Fritz Wrba Austria 38 1.6k 0.9× 1.2k 0.7× 1.3k 0.8× 985 0.9× 262 0.3× 167 4.7k
Tetsuro Kubota Japan 45 2.5k 1.4× 1.6k 0.9× 1.9k 1.2× 2.7k 2.3× 296 0.4× 298 6.7k

Countries citing papers authored by P. Schlag

Since Specialization
Citations

This map shows the geographic impact of P. Schlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schlag more than expected).

Fields of papers citing papers by P. Schlag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Schlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schlag. The network helps show where P. Schlag may publish in the future.

Co-authorship network of co-authors of P. Schlag

This figure shows the co-authorship network connecting the top 25 collaborators of P. Schlag. A scholar is included among the top collaborators of P. Schlag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Schlag. P. Schlag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neeb, Antje, Natalia Novac, P. Schlag, et al.. (2011). The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients. Oncogene. 31(33). 3796–3806. 40 indexed citations
2.
Nordlinger, Bernard, Laurence Collette, Marleen Praet, et al.. (2007). Survival after peri-operative chemotherapy with folfox 4 and surgery for resectable colorectal cancer liver metastases. Final results of the eortc intergroup randomized phase III study 40983. Annals of Oncology. 18. 1 indexed citations
3.
Zhu, Ping, Elke Martin, Jörg Mengwasser, et al.. (2004). Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell. 5(5). 455–463. 411 indexed citations
4.
Tunn, Per‐Ulf & P. Schlag. (2003). Der Riesenzelltumor des Knochens. Eine Analyse von 87 Patienten. Zeitschrift für Orthopädie und ihre Grenzgebiete. 141(6). 690–698. 16 indexed citations
5.
Terpe, H.-J., et al.. (1997). Integrins and E-Cadherin Expression – A Way for the Better Understanding of the Biological Behaviour of Colorectal Cancer. Oncology Research and Treatment. 20(1). 48–52. 1 indexed citations
6.
Sandig, Volker, Christian Hofmann, Susanne Steinert, et al.. (1996). Gene Transfer into Hepatocytes and Human Liver Tissue by Baculovirus Vectors. Human Gene Therapy. 7(16). 1937–1945. 123 indexed citations
7.
Hohenberger, Peter, et al.. (1993). Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H215O and [18F]uracil positron emission tomography (PET). European Journal of Cancer. 29(12). 1682–1686. 18 indexed citations
8.
Brüderlein, Silke, et al.. (1992). Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes and Cancer. 5(1). 91–95. 34 indexed citations
9.
Buhl, K., et al.. (1992). Adjuvant Beta-Interferon Therapy for Gastric Cancer. A Randomized Pilot Study. Oncology Research and Treatment. 15(4). 300–304. 1 indexed citations
10.
Peukert, M., et al.. (1991). Locoregional versus Systemic Chemotherapy in Metastatic Colorectal Cancer – Efficacy of an Additive Immunotherapy with Rubratin. Oncology Research and Treatment. 14(5). 406–410. 3 indexed citations
11.
12.
13.
Białas, Adam, P. Schlag, Peter Friedl, R. Preußmann, & Gerhard Eisenbrand. (1989). Proline is not useful as a chemical probe to measure nitrosation in the gastrointestinal tract of patients with gastric disorders characterised by anacidic conditions.. Gut. 30(8). 1068–1075. 5 indexed citations
14.
Dörsam, J., et al.. (1989). Experiences in Home Care of Cancer Patients A new approach in cancer nursing. Acta Oncologica. 28(1). 35–38. 4 indexed citations
15.
Schlag, P., R. Herrmann, U. Raeth, et al.. (1987). 23. Properative Chemotherapie beim Oesophagus-Carcinom: Vorteile oder Gefahr fr den chirurgischen Eingriff?@@@Preoperative chemotherapy in esophageal cancer ? credits and debits for surgery. Langenbecks Archiv für Chirurgie. 372(1). 155–160. 3 indexed citations
16.
Hohenberger, Peter, P. Schlag, & Ch. Herfarth. (1986). 266. Zur Indikationsstellung operativer Verfahren bei prim�ren und sekund�ren malignen Lebertumoren. Langenbeck s Archives of Surgery. 369(1). 789–789.
17.
Betzler, Monika, W. Schreml, H. -P. Lohrmann, et al.. (1982). Adjuvant Intermittent Chemoimmunotherapy for Primary Breast Cancer: A Prospective Study with Immunologic Follow-Up. Recent results in cancer research. 80. 185–191. 7 indexed citations
18.
Schlag, P., et al.. (1979). [Effect of estradiol on RNA biosynthesis of human breast carcinoma cells in vitro].. PubMed. 183–7. 1 indexed citations
19.
Schlag, P., et al.. (1978). Pretherapeutic cytostatic agent sensitivity testing of breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 231–4. 2 indexed citations
20.
Schlag, P., et al.. (1977). Bakterielle Besiedlung und Nitritbildung im Magen nach Gastroenterostomie: Experimentelle Aspekte zur Pathogenese des Carcinoms im operierten Magen. Langenbecks Archiv für Chirurgie. 344(2). 109–114. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiharu Kamura Breakdown of academic impact, for papers by Simon Karpatkin Breakdown of academic impact, for papers by El–Nasir Lalani Breakdown of academic impact, for papers by Mehrdad Nadji Breakdown of academic impact, for papers by Chandan Guha Breakdown of academic impact, for papers by Phil Gold Breakdown of academic impact, for papers by Andrea Abati Breakdown of academic impact, for papers by Stefania Staibano Breakdown of academic impact, for papers by Fritz Wrba Breakdown of academic impact, for papers by Tetsuro Kubota
Rankless by CCL
2026